These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 18729822)

  • 1. Molecular imaging study on in vivo distribution and pharmacokinetics of modified small interfering RNAs (siRNAs).
    Viel T; Boisgard R; Kuhnast B; Jego B; Siquier-Pernet K; Hinnen F; Dollé F; Tavitian B
    Oligonucleotides; 2008 Sep; 18(3):201-12. PubMed ID: 18729822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural basis for the RNA binding selectivity of oligonucleotide analogues containing alkylsulfide internucleoside linkages and 2'-substituted 3'-deoxyribonucleosides.
    Damha MJ; Meng B; Wang D; Yannopoulos CG; Just G
    Nucleic Acids Res; 1995 Oct; 23(19):3967-73. PubMed ID: 7479044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholesterol-Conjugated Supramolecular Multimeric siRNAs: Effect of siRNA Length on Accumulation and Silencing
    Chernikov IV; Ponomareva UA; Meschaninova MI; Bachkova IK; Teterina AA; Gladkikh DV; Savin IA; Vlassov VV; Zenkova MA; Chernolovskaya EL
    Nucleic Acid Ther; 2023 Dec; 33(6):361-373. PubMed ID: 37943612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LNA incorporated siRNAs exhibit lower off-target effects compared to 2'-OMethoxy in cell phenotypic assays and microarray analysis.
    Puri N; Wang X; Varma R; Burnett C; Beauchamp L; Batten DM; Young M; Sule V; Latham K; Sendera T; Echeverri C; Sachse C; Magdaleno S
    Nucleic Acids Symp Ser (Oxf); 2008; (52):25-6. PubMed ID: 18776235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of double-stranded siRNA labeling method using positron emitter and its in vivo trafficking analyzed by positron emission tomography.
    Hatanaka K; Asai T; Koide H; Kenjo E; Tsuzuku T; Harada N; Tsukada H; Oku N
    Bioconjug Chem; 2010 Apr; 21(4):756-63. PubMed ID: 20210335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo siRNA distribution and pharmacokinetics assessed by nuclear imaging are modulated according to radiolabelling site.
    Garin D; Ahmadi M; Gauchez AS; Bohic S; Boccard S; Cloetens P; Fagret D; Berger F; Briat A; Ghezzi C; Pelletier L
    Nucl Med Biol; 2015 Dec; 42(12):958-66. PubMed ID: 26388159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and properties of oligonucleotide chimeras containing 5'-amino-2'-deoxy-2'-fluoroarabinonucleosides.
    Viazovkina E; Min KL; Galarneau A; Damha MJ
    Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):1335-8. PubMed ID: 14565412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo pharmacokinetics, tissue distribution and underlying mechanisms of various PEI(-PEG)/siRNA complexes.
    Malek A; Merkel O; Fink L; Czubayko F; Kissel T; Aigner A
    Toxicol Appl Pharmacol; 2009 Apr; 236(1):97-108. PubMed ID: 19371615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2'-O-methyl-modified RNAs act as TLR7 antagonists.
    Robbins M; Judge A; Liang L; McClintock K; Yaworski E; MacLachlan I
    Mol Ther; 2007 Sep; 15(9):1663-9. PubMed ID: 17579574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and Discovery of New Combinations of Mutant DNA Polymerases and Modified DNA Substrates.
    Rosenblum SL; Weiden AG; Lewis EL; Ogonowsky AL; Chia HE; Barrett SE; Liu MD; Leconte AM
    Chembiochem; 2017 Apr; 18(8):816-823. PubMed ID: 28160372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [In vivo imaging of liposomal small interfering RNA (siRNA) trafficking by positron emission tomography].
    Ando H; Yonenaga N; Asai T; Hatanaka K; Koide H; Tsuzuku T; Harada N; Tsukada H; Oku N
    Yakugaku Zasshi; 2012; 132(12):1373-81. PubMed ID: 23208044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemical modifications on siRNAs avoid Toll-like-receptor-mediated activation of the hepatic immune system in vivo and in vitro.
    Broering R; Real CI; John MJ; Jahn-Hofmann K; Ickenstein LM; Kleinehr K; Paul A; Gibbert K; Dittmer U; Gerken G; Schlaak JF
    Int Immunol; 2014 Jan; 26(1):35-46. PubMed ID: 24065781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 5' binding MID domain of human Argonaute2 tolerates chemically modified nucleotide analogues.
    Deleavey GF; Frank F; Hassler M; Wisnovsky S; Nagar B; Damha MJ
    Nucleic Acid Ther; 2013 Feb; 23(1):81-7. PubMed ID: 23289589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of siRNA nuclease stability on the in vitro and in vivo kinetics of siRNA-mediated gene silencing.
    Bartlett DW; Davis ME
    Biotechnol Bioeng; 2007 Jul; 97(4):909-21. PubMed ID: 17154307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA interference induced by siRNAs modified with 4'-thioribonucleosides in cultured mammalian cells.
    Hoshika S; Minakawa N; Kamiya H; Harashima H; Matsuda A
    FEBS Lett; 2005 Jun; 579(14):3115-8. PubMed ID: 15919084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Duplex recognition by oligonucleotides containing 2'-deoxy-2'-fluoro-D-arabinose and 2'-deoxy-2'-fluoro-D-ribose. Intermolecular 2'-OH-phosphate contacts versus sugar puckering in the stabilization of triple-helical complexes.
    Wilds CJ; Damha MJ
    Bioconjug Chem; 1999; 10(2):299-305. PubMed ID: 10077480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving RNA interference in mammalian cells by 4'-thio-modified small interfering RNA (siRNA): effect on siRNA activity and nuclease stability when used in combination with 2'-O-alkyl modifications.
    Dande P; Prakash TP; Sioufi N; Gaus H; Jarres R; Berdeja A; Swayze EE; Griffey RH; Bhat B
    J Med Chem; 2006 Mar; 49(5):1624-34. PubMed ID: 16509579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complexity in orchestration of chemical groups near different cleavage sites in RNase P RNA mediated cleavage.
    Brännvall M; Kirsebom LA
    J Mol Biol; 2005 Aug; 351(2):251-7. PubMed ID: 16005891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene-silencing properties of siRNAs that contain internal amide-bond linkages.
    Gong W; Desaulniers JP
    Bioorg Med Chem Lett; 2012 Nov; 22(22):6934-7. PubMed ID: 23062704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rational design and in vitro and in vivo delivery of Dicer substrate siRNA.
    Amarzguioui M; Lundberg P; Cantin E; Hagstrom J; Behlke MA; Rossi JJ
    Nat Protoc; 2006; 1(2):508-17. PubMed ID: 17406276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.